Harpula
Mary Hickey Mattes has a diverse and extensive work experience in the pharmaceutical and clinical research industry. Mary has held various leadership roles in different companies throughout their career.
Mary's most recent position is as the Chief Operating Officer and Founding Partner at Harpula, starting in 2022.
Before that, Mary worked at Synteract, where they held multiple roles. Mary started as the Director of Data Management & Analysis Reporting in 2004 and progressed to become the Senior Vice President of Biometrics & Drug Safety in 2018. As the head of the Global Biometrics and Drug Safety teams, Mary was responsible for identifying and implementing clinical technology solutions and overseeing vendor qualification and selection. Mary played a crucial role in the growth and overall success of Synteract. Mary later became the Chief Operating Officer, driving the company's operational services and setting strategic direction.
Prior to Synteract, Mary worked at Accelovance, Inc. as the Executive Vice President of Global Biometrics & Information Technology. Mary led the Biometrics operational teams, overseeing data management, clinical programming, and biostatistical services. Additionally, Mary was responsible for the global Information Technology infrastructure of the company.
Mary's early career includes roles at PRA Health Sciences, where they started as a Clinical Data Coordinator and progressed to become the Executive Director of Clinical Informatics Delivery. In this role, they were head of the Clinical Informatics Delivery business unit, overseeing client relationships and ensuring the high-quality delivery of drug development services. Mary was also responsible for clinical system vendor management and staff development.
Mary's first role in the industry was at MRL Pharmaceutical Services, where they served as a Project Manager/Micro Analyst. In this position, they managed inter-departmental teams and served as the primary client contact for anti-infective in vitro and clinical trial projects.
Overall, Mary Hickey Mattes has a strong background in operations, biometrics, drug safety, data management, and clinical informatics, with a track record of leadership and successful delivery of services in the pharmaceutical and clinical research industry.
Mary Hickey Mattes holds a Bachelor's Degree from The College of Saint Rose, where they focused on Biology with a specialization in genetics and a minor in Chemistry. No specific start or end dates were provided for their education.
This person is not in any teams
This person is not in any offices
Harpula
Harpula was formed to foster the growth of next generation technology and services for clinical trials. Our goal is to build a company that excels in today’s clinical trial landscape of personalized medicine, multiple trial modalities, and increased patient centricity. Harpula builds on the founders’ years of experience in clinical trial execution and technology. We recognize the opportunity to build a more coordinated technology solution through acquisition and organic growth. We seek to invest in companies and assets in the technology-enabled pharmaceutical solutions industry to improve the clinical trial experience for patients, sites, and sponsors. Technology solutions have had a tremendously positive impact on the quality and efficiency of clinical trials. As the number and type of solutions have propagated, the burden on sponsors, sites, and patients has increased. There is opportunity to consolidate platforms to address critical pain points around the patient and site experience and ultimately deliver drugs to patients faster.